Piperidolate
Piperidolate is a pharmaceutical drug used to treat the symptoms of gastrointestinal disorders including gastric and duodenal ulcers, gastritis, enteritis, gallstones, cholecystitis, and biliary dyskinesia.[1] It acts as an antimuscarinic agent.[2] It was first approved in 1954 and is no longer marketed in the United States.[1]
Clinical data | |
---|---|
Trade names | Dactil |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.001.318 |
Chemical and physical data | |
Formula | C21H25NO2 |
Molar mass | 323.436 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
References
- "Piperidolate". Inxight Drugs. National Center for Advancing Translational Sciences.
- "Piperidolate". drugs.com.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.